Emergent Biosolutions
EBS
EBS
263 hedge funds and large institutions have $2.61B invested in Emergent Biosolutions in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 87 increasing their positions, 95 reducing their positions, and 20 closing their positions.
Holders
263
Holders Change
+27
Holders Change %
+11.44%
% of All Funds
5.81%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.11%
New
50
Increased
87
Reduced
95
Closed
20
Calls
$1.49M
Puts
$2.36M
Net Calls
-$874K
Net Calls Change
+$1.21M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
276
Shelton Capital Management
Denver,
Colorado
| – | -$212K | -3,922 | Closed |
|
277
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$183K | -3,400 | Closed |
|
|
PHK
278
Point72 Hong Kong
Hong Kong
| – | -$69K | -1,271 | Closed |
|
|
EW
279
Evoke Wealth
Los Angeles,
California
| – | -$49.5K | -917 | Closed |
|
|
FIB
280
First Interstate Bank
Billings,
Montana
| – | -$22K | -415 | Closed |
|
|
PA
281
Parallel Advisors
San Francisco,
California
| – | -$6K | -114 | Closed |
|
|
CHAM
282
Clear Harbor Asset Management
Stamford,
Connecticut
| – | -$809 | -15 | Closed |
|